CORDIS CROWNs 1997 WITH NEXT-GENERATION CORONARY STENT APPROVAL; FULL-SCALE U.S. LAUNCH BEGINS JAN. 1 THROUGH 100-PERSON DIRECT SALES FORCE
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Cordis unit began rolling out its Crown second-generation, balloon-expandable coronary stent Jan. 1, seeking to prolong its reign in an increasingly competitive market. Cordis will leverage its 100 person sales force so as to rapidly seed the market with its latest stent offering, parent J&J said Dec. 22 following FDA approval of the device on Dec. 19.